Log In
BCIQ
Print this Print this
 

CF-306

  Manage Alerts
Collapse Summary General Information
Company ContraFect Corp.
DescriptionAnthrax specific lysin protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentDiscovery
Standard IndicationBacteremia
Indication DetailsTreat bacteremia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today